Why Is Qualigen Therapeutics (QLGN) Stock Down 12% Today?

Advertisement

  • Qualigen Therapeutics (QLGN) stock is falling on Monday.
  • This follows a rally for the shares on Friday.
  • QLGN may be volatile due to its penny stock status.
QLGN Stock - Why Is Qualigen Therapeutics (QLGN) Stock Down 12% Today?

Source: Numstocker/Shutterstock.com

Qualigen Therapeutics (NASDAQ:QLGN) stock is sliding lower on Monday as the clinical-stage therapeutics company’s shares come off of a rally on Friday.

That rally saw shares of QLGN stock soar more than 59% higher during normal trading hours. This came alongside 244 million shares of the stock changing hands. That’s a massive increase over its daily average trading volume of about 5.4 million shares. Investors will note that the float for Qualigen Therapeutics is 9.59 million units.

QLGN stock isn’t seeing nearly as much movement on Monday morning. Only about 1.4 million shares of the stock have been traded as of this writing. With that comes a 12% drop for Qualigen Therapeutics’ shares this morning.

What’s Behind Friday’s Rally

There was no news from Qualigen Therapeutics that would cause its shares to take off like they did on Friday. That includes a lack of press releases or filings with the Securities and Exchange Commission (SEC). It also doesn’t appear that analyst coverage was behind the surge.

However, traders will keep in mind that QLGN is a penny stock. That means it’s subject to volatility. This can happen with speculative traders buying shares or retail and day traders pumping the stock. No matter the case, investors will want to be careful about taking a stake in QLGN right now.

Investors will want to stick around for more of the most recent stock market stories today!

We have all of the hottest news moving shares on Monday morning! That includes what’s happening with shares of China Liberal Education (NASDAQ:CLEU) stock, Shapeways (NASDAQ:SHPW) stock and Inspire Veterinary (NASDAQ:IVP) stock today. All of that info is ready at the following links!

More Stock Market News for Monday

On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.

Read More: Penny Stocks — How to Profit Without Getting Scammed

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.


Article printed from InvestorPlace Media, https://investorplace.com/2024/07/why-is-qualigen-therapeutics-qlgn-stock-down-12-today/.

©2024 InvestorPlace Media, LLC